4.7 Review

The P300 event-related potential in bipolar disorder: A systematic review and meta-analysis

Journal

JOURNAL OF AFFECTIVE DISORDERS
Volume 256, Issue -, Pages 234-249

Publisher

ELSEVIER
DOI: 10.1016/j.jad.2019.06.010

Keywords

Bipolar disorder; Cognition; Electrophysiology; Biological markers; EEG/Event-related potentials

Funding

  1. Japan Agency for Medical Research and development (AMED) [20807226]
  2. CIHR
  3. AMED
  4. Takeda Science Foundation
  5. Uehara Memorial Foundation
  6. Healthy Brains for Healthy LivesPostdoctoral Fellowship
  7. Japan Society for the Promotion of Science
  8. TEIJIN PHARMA LIMITED
  9. Japan Health Foundation
  10. Meiji Yasuda Mental Health Foundation
  11. Mitsui Life Social Welfare Foundation
  12. SENSHIN Medical Research Foundation
  13. Health Science Center Foundation
  14. Mochida Memorial Foundation for Medical and Pharmaceutical Research
  15. Daiichi Sankyo Scholarship Donation Program
  16. Magventure Inc.
  17. Japan Research Foundation for Clinical Pharmacology
  18. Naito Foundation
  19. KAKENHI [20807226]

Ask authors/readers for more resources

Background: Neurophysiology including P300, that is a typical index of event-related potential, may be potential biomarkers for bipolar disorder (BD) and it can be useful towards elucidating the pathophysiology of BD. However, previous findings from P300 studies were inconsistent due to the heterogeneity of research methods, which make it difficult to understand the neurobiological significance of them. The aim of this study is to conduct a meta-analysis on P300 in patients with BD. Method: A literature search was conducted using PubMed to identify studies that compared P300 event-related potential between patients with BD and healthy controls (HCs). We analyzed P300 indices such as amplitude and latency of P3a and P3b in auditory or visual paradigms. Further, moderator analyses were conducted to investigate the influence of patient characteristics (i.e. history of psychosis, diagnostic subcategories [BD-I/BD-II], and phase of illness [euthymic, manic, or depressive]) on P300 indices. Result: Out of 124 initial records, we included 30 articles (BD: N = 1331; HCs: N = 1818). Patients with BD showed reduced P3a and P3b amplitude in both paradigms and delayed P3b latency in auditory paradigms compared to HCs. There was no influence on the history of psychosis, diagnostic subcategories, or phase of illness on P300 indices. Limitation: The difference in medication use was difficult to control and it may affect the results. Conclusion: This meta-analysis provides evidence for P300 abnormalities in patients with BD compared to HCs. Our results suggest that P300 may be trait markers rather than state markers in this illness.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available